Glucagon Like Peptide 1 Analogs Market Estimated to Witness Strong Growth Fueled by Increasing Prevalence of Diabetes
Glucagon like peptide 1 (GLP-1) analogs are injectable drugs that help control blood sugar levels in patients with type 2 diabetes. GLP-1 analogs work by stimulating the release of insulin from the pancreas and suppressing the release of glucagon which helps lower blood glucose levels. They also help slow the emptying of the stomach and promote sat